Oral small molecule therapeutics

Search documents
Structure Therapeutics to Participate in Two Upcoming Healthcare Investor Conferences
Globenewswireยท 2025-09-02 12:30
SAN FRANCISCO, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic diseases, with a focus on obesity, today announced that management will participate in two upcoming healthcare conferences in September. Cantor Global Healthcare Conference Format:Fireside chat and 1x1 meetings Date/time:Wednesday, September 3 at 3:55 p.m. ET Location:New York, NY Morgan Stanley 23rd ...